In the latest trading session, Gilead Sciences (GILD) closed at $134.25, marking a -1.92% move from the previous day. This move lagged the S&P 500's daily loss of 1.67%. On the other hand, the Dow ...

Northwestern University scientists developed HOBIT, a wireless implant that produces three different drugs simultaneously for ...

New details of Gov. Mikie Sherrill’s $60.7 billion budget proposal have nonprofits warning of catastrophic losses of state ...

David Beran and colleagues argue that the GLP-1 receptor agonists might not have been appropriate for addition to the 2025 WHO Essential Medicines List (EML) for three reasons.e First, the authors ...

Florida law restores HIV/AIDS medications for thousands who’d been cut from the rolls. Widely used Biktarvy won’t be covered ...

Gọọmentị Naịjirịa amalitela ikesa ọgwụ mgbochi nje HIV a kpọrọ Lenacapavir, mana ha dọrọ aka na ntị ka ụmụnwaanyị dị ime ...

Nigeria's disease prevention scheme has successfully enrolled over 6.5 million pregnant women, a milestone in preventing ...

Tuberculosis remains a leading cause of death worldwide among persons with HIV. In this report, the effect of the PEPFAR ...

A novel regimen of doravirine and islatravir was noninferior to a common HIV therapy as an initial HIV treatment, according ...

Objective Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug ...

Looking at the statistics, it can confidently be said that over the past quarter century, Estonia has caught up with the ...

The HIV prevention shot lenacapavir will be rolled out at South African clinics within the next few months – from 2027, the ...